New York, NY, June 08, 2023 (GLOBE NEWSWIRE) -- Polaris Market Research has published a new research report titled “Monoclonal Antibodies in Veterinary Health Market Share, Size, Trends, Industry Analysis Report, By Animal Type (Dogs, Others); By Application (Dermatology, Pain, Others); By End-Use; By Region; Segment Forecast, 2023 - 2032” in its research database.
“As per the latest research analysis, the global monoclonal antibodies in veterinary health market size/share will be valued at roughly USD 785.71 Million in 2022, and its revenue is projected to reach about USD 3,425.91 Million By 2032. The market is forecasted to expand at a compound annual growth rate of approximately 15.98% between 2023 and 2032.”
What is the Market for Monoclonal Antibodies in Veterinary Health?
- Overview
Monoclonal antibodies are also commonly known as moAbs or mAbs. It is a kind of laboratory-produced protein that can bind to particular bodily targets, like antigens on the texture of cancer cells. Every monoclonal antibody is developed to attach to a single antigen, and numerous varieties of these antibodies exist.
Many diseases, including some forms of cancer, are diagnosed and treated using monoclonal antibodies. The monoclonal antibodies in veterinary health market are expanding due to the creation of novel monoclonal antibodies, rising pet costs, allergy therapies, and an increase in cancer cases, particularly in dogs.
Request Sample Copy of Monoclonal Antibodies in Veterinary Health Market Research Report @ https://www.polarismarketresearch.com/industry-analysis/monoclonal-antibodies-in-veterinary-health-market/request-for-sample
(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)
Our Sample Report Covers:
- 2032 Updated Report Introduction, Overview, and In-depth industry analysis.
- 115+ Pages Research Report (Inclusion of Updated Research).
- Provide Chapter-wise guidance on Requests.
- 2023 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
- Includes Updated List of tables & figures.
- Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis.
Some of the Top Market Players Are:
- Adivo GmbH
- Bayer Animal Health
- Boehringer Ingelheim GmbH
- Elanco; Indian Immunologicals Ltd.
- Invetx
- Kindred Biosciences Inc.
- Merck & Co. Inc
- Nextmune
- Virbac
- Zoetis
To Know an Additional List of Key Players, Request Here to Download a Free Report PDF Brochure: https://www.polarismarketresearch.com/industry-analysis/monoclonal-antibodies-in-veterinary-health-market/request-for-sample
Prominent Growth Driving Factors
- Expanded prevalence of chronic diseases: One of the primary drivers of the increasing monoclonal antibodies in veterinary health market share is the rising prevalence of chronic diseases in companion animals, such as cancer and arthritis. The mAbs treat infectious disorders like parvovirus, feline leukemia virus, and chronic diseases. mAbs are a crucial tool in veterinary medicine because of their ability to increase animal welfare and stop the spread of disease in animal populations.
- Technological advancements: The development of more accurate and efficient monoclonal antibodies for veterinary usage is facilitated by biotechnology advances. Innovative medicines are possible through advanced technology like bioprinting and gene editing. These developments should accelerate the market's expansion even more.
- Increasing pet ownership: The market is expanding because of growing pet ownership and spending. Pet owners are ready to spend more on their animals' healthcare is driving demand for more advanced and effective treatments like monoclonal antibodies.
Top Findings of the Report
- The monoclonal antibodies in veterinary health market size are expanded due to the rising pet adoption rate. Additionally, the industry is making significant investments in cancer treatment research & development, which is anticipated further to fuel market expansion throughout the anticipated period.
- The market segmentation is based on application, animal type, region, and end-use.
- North America dominates the market during the forecast period.
Request for a Discount on this Report Before Purchase @ https://www.polarismarketresearch.com/industry-analysis/monoclonal-antibodies-in-veterinary-health-market/request-for-discount-pricing
Top Trends Influencing the Market
- Treating chronic disorders: The monoclonal antibodies in veterinary health market growth is anticipated to expand rapidly as chronic diseases, including diabetes, cancer, and autoimmune disorders, become increasingly prevalent in animals, just as they are in humans. These disorders can be effectively and precisely treated using monoclonal antibodies, which has raised the demand for these treatments.
- Collaborations and partnerships: More innovative treatments for animal disorders are being developed due to partnerships and cooperation between biotech and pharmaceutical businesses, veterinary clinics, and research organizations. Market growth is anticipated to be further accelerated by regulatory approvals of monoclonal antibodies for veterinary medicine by regulatory organizations like the FDA and EMA.
Segmental Analysis
- Dogs sector accounts for the highest revenue share
Due to the increasing popularity of dogs as pets and the rising cost of maintaining their health, the dogs segment had the biggest revenue share. The rise in pet insurance adoption and the prevalence of chronic animal diseases have contributed to the market's revenue growth.
Moreover, the market is growing as pet insurance is increasingly popular. More people will spend more on their pets' medical care, including advanced treatments like monoclonal antibodies. This trend is anticipated to accelerate monoclonal antibodies in veterinary health market demand.
- The veterinary hospital sector dominates the market
The veterinary hospital sector dominated the market's revenue share. The expansion of veterinary hospitals and veterinarians is responsible for the industry's growth. Due to the accessibility of innovative treatments, veterinary hospitals have made huge profits.
Moreover, the "others" sector of the market, which includes research organizations, veterinary clinics, and academic institutions, is anticipated to see revenue growth.
Inquire more about this report before purchase @ https://www.polarismarketresearch.com/industry-analysis/monoclonal-antibodies-in-veterinary-health-market/inquire-before-buying
(Inquire about a report quote OR available discount offers to the sales team before purchase.)
Monoclonal Antibodies in Veterinary Health Market: Report Scope
| Report Attribute | Details |
| Revenue forecast in 2032 | USD 3,425.91 Million |
| Market size value in 2023 | USD 902.43 Million |
| Expected CAGR Growth | 15.98% from 2023 – 2032 |
| Base Year | 2022 |
| Forecast Year | 2023 – 2032 |
| Top Market Players | Adivo GmbH, Bayer Animal Health, Boehringer Ingelheim GmbH, Elanco; Indian Immunologicals Ltd., Invetx, Kindred Biosciences, Inc., Merck & Co. Inc, Nextmune, Virbac, Zoetis |
| Segments Covered | By Animal Type, By Application, By End-Use, By Region |
| Customization Options | Customized purchase options are available to meet any research needs. Explore customized purchase options |
Geographical Overview
North America: Due to the initiatives supported by the public and private sectors and the rising popularity of pet insurance, the North American region dominated the global market. The presence of prominent market players further increases the market growth.
Asia Pacific: The monoclonal antibodies in veterinary health market in Asia Pacific are anticipated to have the biggest revenue share despite the growing number of veterinary hospitals and clinics in the area that competes with it. The industry is expected to develop as pet adoption rises, disease awareness increases, and more alternative therapy types are available.
Browse the Detail Report “Monoclonal Antibodies in Veterinary Health Market Share, Size, Trends, Industry Analysis Report, By Animal Type (Dogs, Others); By Application (Dermatology, Pain, Others); By End-Use; By Region; Segment Forecast, 2023 - 2032” with in-depth TOC: https://www.polarismarketresearch.com/industry-analysis/monoclonal-antibodies-in-veterinary-health-market
For Additional Information OR Media Enquiry, Please Mail At: sales@polarismarketresearch.com
Recent Developments
- Elanco announced an agreement to purchase Kindred Biosciences in August 2021. The deal completes the pipeline, boosts the R&D capacity for monoclonal antibodies, and includes three potential blockbusters in the development stage.
- Invetx, a Boston-based leader in protein-based therapeutics for animal health, and Boehringer Ingelheim, a global leader in veterinary medicine, announced in September 2021 that they had collaborated to develop novel, species-specific monoclonal antibody biotherapeutics that will initially target illnesses in dogs and cats.
The Report Answers Questions Such as
- What is the estimated market value of monoclonal antibodies in veterinary health?
- What are the key market growth drivers?
- Who are the key players in the industry?
- What opportunities and trends drive the monoclonal antibodies in the veterinary health market?
- Which segment holds the highest market share?
- At what CAGR is the market expected to grow during the forecast period?
Polaris Market Research has segmented the Monoclonal Antibodies in Veterinary Health market report based on animal type, application, end-user, and region:
By Animal Type Outlook
- Dogs
- Others
By Application Outlook
- Dermatology
- Pain
- Others
By End-Use Outlook
- Veterinary hospitals
- Others
By Region Outlook
- North America (U.S., Canada)
- Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
- Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
- Latin America (Brazil, Mexico, Argentina)
- Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
Browse More Research Reports:
- Cash Management Systems Market: https://www.polarismarketresearch.com/industry-analysis/cash-management-system-market
- Pipe Insulation Market: https://www.polarismarketresearch.com/industry-analysis/pipe-insulation-market
- Almond Butter Market: https://www.polarismarketresearch.com/industry-analysis/almond-butter-market
- BFSI Crisis Management Market: https://www.polarismarketresearch.com/industry-analysis/bfsi-crisis-management-market
- Low-speed electric vehicle (LSEV) Market: https://www.polarismarketresearch.com/industry-analysis/low-speed-electric-vehicle-lsev-market
- Thin Film Encapsulation Market: https://www.polarismarketresearch.com/industry-analysis/thin-film-encapsulation-tfe-market
- Fishmeal and Fish Oil Market: https://www.polarismarketresearch.com/industry-analysis/fishmeal-and-fish-oil-market
About Polaris Market Research:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR’s clientele spread across different enterprises. We at Polaris are obliged to serve PMR’s diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR’s customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR’s customers.
Contact:
Likhil G
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
Blog: https://polarismarketresearch.medium.com | https://polarisnewsblog.com
